Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort
European Heart Journal: Acute Cardiovascular Care · 2023
DOI: 10.1093/ehjacc/zuad042 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2023. Verfasst von Muhammed T Gürgöze und 22 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus MC, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: C-Reactive Protein, Acute Coronary Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: COBAS C, COBAS E, ELECSYS.
Abstract (Originalsprache)
Aims
Evidence regarding the role of serial measurements of biomarkers for risk assessment in post-acute coronary syndrome (ACS) patients is limited. The aim was to explore the prognostic value of four, serially measured biomarkers in a large, real-world cohort of post-ACS patients. Methods and results BIOMArCS is a prospective, multi-centre, observational study in 844 post-ACS patients in whom 12 218 blood samples (median 17 per patient) were obtained during 1-year follow-up. The longitudinal patterns of high-sensitivity cardiac troponin T (hs-cTnT), N-terminal-pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein (hs-CRP), and growth differentiation factor 15 (GDF-15) were analysed in relation to the primary endpoint (PE) of cardiovascular mortality and recurrent ACS using multivariable joint models. Median age was 63 years, 78% were men and the PE was reached by 45 patients. The average biomarker levels were systematically higher in PE compared with PE-free patients. After adjustment for 6-month post-discharge Global Registry of Acute Coronary Events score, 1 standard deviation increase in log[hs-cTnT] was associated with a 61% increased risk of the PE [hazard ratio (HR) 1.61, 95% confidence interval (CI) 1.02–2.44, P = 0.045], while for log[GDF-15] this was 81% (HR 1.81, 95% CI 1.28–2.70, P = 0.001). These associations remained significant after multivariable adjustment, while NT-proBNP and hs-CRP were not. Furthermore, GDF-15 level showed an increasing trend prior to the PE (Structured Graphical Abstract).
Conclusion
Longitudinally measured hs-cTnT and GDF-15 concentrations provide prognostic value in the risk assessment of clinically stabilized patients post-ACS. Clinical Trial Registration The Netherlands Trial Register. Currently available at URL https://trialsearch.who.int/; Unique Identifiers: NTR1698 and NTR1106.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Erasmus MC, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands.
- Department of Cardiology, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, 3318 AT, Dordrecht, the Netherlands.
- Department of Cardiology, Northwest Clinics, Wilhelminalaan 12, 1815 JD, Alkmaar, the Netherlands.
- Department of Cardiology, Zuyderland Hospital, Henri Dunantstraat 5, 6419 PC, Heerlen, the Netherlands.
- Department of Cardiovascular Medicine, Mayo Clinic, 201-299 2nd Ave SW, Rochester, MN 55902, USA.
- Department of Cardiology, HagaZiekenhuis, Leyweg 275, 2545 CH, Den Haag, the Netherlands.
ORCID-Profile: Muhammed T Gürgöze, Timo Lenderink, Eric Boersma
Förderung
- COBAS C
- COBAS E
- ELECSYS
- Netherlands Heart Foundation
- Netherlands Heart Institute-Interuniversity Cardiology Institute of Netherlands
- Working Group of Cardiovascular Research Netherlands
- Eli Lilly
Zitieren
APA
Gürgöze, M. T., Akkerhuis, K. M., Oemrawsingh, R. M., Umans, V. A. W. M., Kietselaer, B., Schotborgh, C. E., Ronner, E., Lenderink, T., Aksoy, I., van der Harst, P., Asselbergs, F. W., Maas, A. C., Oude Ophuis, A. J., Krenning, B., de Winter, R. J., The, S. H. K., Wardeh, A. J., Hermans, W. R. M., Cramer, G. E., …, & Boersma, E. (2023). Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuad042
Vancouver
Gürgöze MT, Akkerhuis KM, Oemrawsingh RM, Umans VAWM, Kietselaer B, Schotborgh CE, et al. Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort. European Heart Journal: Acute Cardiovascular Care. 2023. doi:10.1093/ehjacc/zuad042
BibTeX
@article{Grgze2023,
author = {Gürgöze, Muhammed T and Akkerhuis, K Martijn and Oemrawsingh, Rohit M and Umans, Victor A W M and Kietselaer, Bas and Schotborgh, Carl E and Ronner, Eelko and Lenderink, Timo and Aksoy, Ismail and van der Harst, Pim and Asselbergs, Folkert W and Maas, Arthur C and Oude Ophuis, Anton J and Krenning, Boudewijn and de Winter, Robbert J and The, Salem H K and Wardeh, Alexander J and Hermans, Walter R M and Cramer, G Etienne and van Gorp, Ina and de Rijke, Yolanda B and van Schaik, Ron H N and Boersma, Eric},
title = {Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort},
journal = {European Heart Journal: Acute Cardiovascular Care},
year = {2023},
doi = {10.1093/ehjacc/zuad042}
}
EUVIMED